Target intelligence / Profile preview

DNA and RNA synthesis machinery

Molecular classification
Enzyme, Ribonucleoprotein complex, Other (multi-protein and nucleic acid assemblies)
01

Overview

The DNA and RNA synthesis machinery refers collectively to the cellular systems responsible for replicating genetic material (DNA replication), transcribing DNA into RNA (transcription), and translating RNA into proteins (translation). Key components include DNA polymerases, RNA polymerases, ribosomes, and various accessory factors (e.g., primase, transcription factors, splicing factors). While these processes are vital for all cellular life, their individual components can serve as drug targets, especially in pathogens (e.g., bacterial RNA polymerase, viral reverse transcriptase) or rapidly proliferating cells (e.g., cancer). However, the broad term "DNA and RNA synthesis machinery" does not designate a specific molecular target, but rather a functional category encompassing multiple, distinct macromolecules essential for gene expression and cell viability.

Other names
Gene expression machineryNucleic acid synthesis enzymesTranscription and replication complexesPolymerase complexesTranslational apparatus
02

Mechanism of action

Inhibition of polymerase active sites (blocking DNA or RNA synthesis); Blocking ribosomal function (antibiotics binding to rRNA); Chain termination (nucleoside analogs)

03

Biological functions

DNA replicationRNA transcriptionProtein translationCell proliferationCell cycleGene expression regulationOther (e.g., splicing, RNA maturation)
04

Disease associations

CancerInfection (many antibiotics and antivirals target these machineries)Neurodegenerative disease (mutations in ribosomal or RNA-processing genes)Anemia (e.g., Diamond Blackfan anemia)Myopathies, diabetes, rare genetic disorders
05

Safety considerations

Off-target toxicity (normal cells rely on the same synthesis machinery as diseased cells, leading to myelosuppression, mucositis, etc.)Specific side effects depend on the targeted enzyme (e.g., anemia with ribosome impairments, hepatotoxicity with nucleoside analogs)Resistance development (mutations in target subunits)
06

Interacting drugs

Nucleoside analogs (e.g., acyclovir, zidovudine, cytarabine target DNA polymerases)

3 more in the full profile.

07

Biomarkers

Expression levels/mutations of DNA polymerase, RNA polymerase, or ribosomal proteins in cancerrRNA mutation or abundance (for ribosomal antibiotics)Transcription signature panels

Beyond the preview

Go deeper on DNA and RNA synthesis machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA and RNA synthesis machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call